ArticleInfectious Disease Modelling2025
Estimating the effect of contact tracing during the early stage of an epidemic.
Article in Infectious Disease Modelling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contact tracing is an important public health measure to control disease transmission. However, it is difficult to assess contact tracing during the exponential stage of an epidemic with multiple control measures, because the exponential growth rate is influenced by all measures. We present new SEIR and SEAIR contact tracing models that track contacts in randomly mixed populations, and calibrate them to simulated epidemic curves to determine the data that allow us to assess the effect of contact tracing. We find that new-case counts, counts of cases identified by contact tracing (or voluntary tests), and counts of symptomatic onset are necessary to identify model parameters and evaluate the effect of contact tracing. We fit our contact tracing models to COVID-19 pandemic data in Ontario, Canada, during March 16-May 1, 2020. Our results show that approximately 29% of cases were identified via contact tracing of close contacts. Contact tracing moderately reduces the control reproduction number by about 25%, but significantly reduces the prevalence by more than half. Ignoring asymptomatic transmissions gives similar estimates for the effect of contact tracing, but significantly underestimates the prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.